314
Participants
Start Date
April 8, 2020
Primary Completion Date
June 28, 2021
Study Completion Date
July 30, 2021
Auxora (Part 1)
Auxora will be given at 2.0 mg/kg (1.25 mL/kg) on Day 1 and then 1.6 mg/kg (1.0 mL/kg) on Days 2 and 3. All doses of Auxora will be administered intravenously (IV) over 4 hours.
Standard of Care (Part 1)
Patients received standard of care
Auxora (Part 2)
Auxora will be given at 2.0 mg/kg (1.25 mL/kg) on Day 1 and then 1.6 mg/kg (1.0 mL/kg) on Days 2 and 3. All doses of Auxora will be administered intravenously (IV) over 4 hours.
Placebo (Part 2)
Placebo will be given at 2.0 mg/kg (1.25 mL/kg) on Day 1 and then 1.6 mg/kg (1.0 mL/kg) on Days 2 and 3. All doses of Placebo will be administered intravenously (IV) over 4 hours.
Virginia Commonwealth University, Richmond
Henry Ford Hospital, Detroit
Sinai Grace, Detroit
Aurora Baycare, Green Bay
Regions Hospital, Saint Paul
Methodist Hospital, Saint Louis Park
Northwestern University, Chicago
Baton Rouge General, Baton Rouge
John Peter Smith Hospital, Fort Worth
Houston Methodist Hospital, Houston
Texas Tech University Medical Center, El Paso
National Jewish Health / St. Joseph's Hospital, Denver
University of Southern California / LA County, Los Angeles
Long Beach Memorial, Long Beach
Sharp Memorial San Diego, San Diego
Maine Medical Center, Portland
Brigham and Women's Hospital, Boston
Lead Sponsor
CalciMedica, Inc.
INDUSTRY